Avidity Biosciences, Inc. (RNA)

Last Closing Price: 34.41 (2025-06-03)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Avidity Biosciences, Inc. (RNA) had Net Income of $-322.30M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$10.90M
Net Income
$-322.30M
--
$10.90M
$389.83M
$-378.94M
$56.63M
$-322.30M
$-322.30M
$-322.30M
$-322.30M
$-322.30M
$-322.30M
$-378.94M
$-397.61M
111.58M
111.58M
$-2.89
$-2.89
Balance Sheet Financials
$1.54B
$12.67M
$21.61M
$1.56B
$98.02M
--
$40.92M
$138.94M
$1.42B
$1.42B
$1.42B
119.89M
Cash Flow Statement Financials
$-300.87M
$-854.20M
$1.19B
$185.38M
$222.66M
$37.29M
$51.36M
--
--
Fundamental Metrics & Ratios
15.73
--
--
--
--
100.00%
-3477.43%
-3477.43%
-3648.77%
-2957.71%
-2957.71%
$-307.94M
--
--
--
0.01
--
--
--
-22.62%
-22.62%
-20.61%
-22.62%
$11.89
$-2.76
$-2.70